貨號(hào)	規(guī)格	價(jià)格	上海	北京	武漢	南京
S80985-5mg	99.3%	￥270.00 S80985-5mg ￥270.00 現(xiàn)貨	4 4	-	-	-
S80985-10mg	99.3%	￥500.00 S80985-10mg ￥500.00 現(xiàn)貨	4 4	-	-	-
S80985-25mg	99.3%	￥920.00 S80985-25mg ￥920.00 現(xiàn)貨	4 4	-	-	-
S80985-100mg	≥98%	￥3300.00 S80985-100mg ￥3300.00 2-3天	0 貨期：2-3天	-	-	-

產(chǎn)品介紹

PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.

產(chǎn)品描述：

PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.

靶點(diǎn)：

CDK;cholecystokinin;GSK-3;cholecystokinin;GSK-3;CDK

體外研究：

PHA-767491降低Chk1磷酸化并增加從裸鼠HCC異種移植物切片的腫瘤組織中的原位細(xì)胞凋亡

體內(nèi)研究：

PHA-767491抑制兩種細(xì)胞系的增殖,在HCC1954細(xì)胞中的IC50為0.64 μM,在Colo-205細(xì)胞中的IC50為1.3 μM。PHA-767491（2 μM）在HCC1954細(xì)胞中24小時(shí)完全消除Mcm2磷酸化。PHA-767491與5-FU聯(lián)用對(duì)HCC細(xì)胞表現(xiàn)出更強(qiáng)的細(xì)胞毒性并誘導(dǎo)顯著的凋亡,表現(xiàn)為顯著增加的胱天蛋白酶3激活和聚（ADP-核糖）聚合酶片段化。 PHA-767491直接抵消5-FU誘導(dǎo)的Chk1的磷酸化并降低抗凋亡蛋白髓性白血病細(xì)胞1ine的表達(dá)。 PHA-767491（0-10 μM）以時(shí)間和劑量依賴方式降低成膠質(zhì)細(xì)胞瘤細(xì)胞活力,U87-MG和U251-MG細(xì)胞的IC50約為2.5 μM

細(xì)胞實(shí)驗(yàn)：

For assays in 96 well plates 2500 cells are plated per well. After 24 hours, cells are treated with small molecule inhibitors and incubated for 72 hours at 37°C. Subsequently the cells are lysed and the ATP content is measured as an indicator of metabolically active cells using the CellTiter-Glo assay. IC50 values are calculated using the GraphPad software. For assays in six well plates, 100,000 cells are plated per well. After 24 hours, cells are treated with small molecule inhibitors and incubated for varying time points. Cells are trypsinized and a suspension is made in 5 mL of phosphate buffered saline. 30 μL of this suspension is mixed with 30 μL of CellTiter-Glo reagent followed by a 10-minute incubation at room temperature. Luminescence is measured using EnVision 2104 Multilabel Reader and BioTek Synergy Neo Microplate Reader.

參考文獻(xiàn)：

1. Yecies D, et al. Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1. Blood, 2010, 115(16), 3304-3313. 2. Natoni A, et al. Mechanisms of action of a dual Cdc7/Cdk9 kinase inhibitor against quiescent and proliferating CLL cells. Mol Cancer Ther, 2011, 10(9), 1624-1634. 3. Montagnoli A, et al. A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity. Nat Chem Biol, 2008, 4(6), 357-365.

溶解性：

soluble in DMSO

保存條件：

-20℃

配置溶液濃度參考：

	1mg	5mg	10mg
1 mM	4.69 ml	23.448 ml	46.896 ml
5 mM	0.938 ml	4.69 ml	9.379 ml
10 mM	0.469 ml	2.345 ml	4.69 ml
50 mM	0.094 ml	0.469 ml	0.938 ml

注意：

部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。

參考文獻(xiàn)

質(zhì)檢證書(COA)

輸入產(chǎn)品批號(hào)：

如何獲取質(zhì)檢證書(COA)?

請(qǐng)輸入貨號(hào)和一個(gè)與之匹配的批號(hào)。
例如:
批號(hào)：JS298415 貨號(hào)：S20001-25g
在貨品標(biāo)簽上如何找到貨號(hào)和批號(hào)?

摩爾濃度計(jì)算器

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

質(zhì)量

濃度

體積

分子摩爾量

計(jì)算重置

国产精品+调教,sao货水真多把你cao烂动态,小说女频修仙,被合租刑警的粗汉肉h高np,波多官能人小说电影番号,我的姐夫是太子小说全集完整版txt,男生和女生一起差差差很痛的app下载,午夜福利日本精品,亲嘴一边揉一边往下摸视频

PHA-767491